PUBLIC COMPANY
save$VTGNVistagen Therapeutics, Inc.
$VTGNSouth San Francisco, CA, USupdated 2mo ago
community read0 votes
pipeline
5
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
4Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
- phase2PH94B in the Treatment of Adjustment Disorder With Anxiety
- phase2A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
- phase3PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
- phase3Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
- phase3PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Apr 7, 26grantTressler Nick B. · Chief Financial Officer75,000 sh
- Apr 7, 26grantSingh Shawn · President and CEO3,732 sh
- Apr 7, 26grantSingh Shawn · President and CEO71,268 sh
- Apr 7, 26grantPrince Joshua S. · Chief Operating Officer18,752 sh
- Apr 7, 26grantPrince Joshua S. · Chief Operating Officer56,248 sh
- Apr 7, 26grantCote Elissa S. · Chief Corp Development Officer75,000 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that